XTANT MEDICAL (Germany) Market Value

XMS Stock  EUR 0.51  0.01  1.92%   
XTANT MEDICAL's market value is the price at which a share of XTANT MEDICAL trades on a public exchange. It measures the collective expectations of XTANT MEDICAL HLDGS investors about its performance. XTANT MEDICAL is trading at 0.51 as of the 24th of July 2025. This is a 1.92 percent down since the beginning of the trading day. The stock's lowest day price was 0.51.
With this module, you can estimate the performance of a buy and hold strategy of XTANT MEDICAL HLDGS and determine expected loss or profit from investing in XTANT MEDICAL over a given investment horizon. Check out XTANT MEDICAL Correlation, XTANT MEDICAL Volatility and XTANT MEDICAL Alpha and Beta module to complement your research on XTANT MEDICAL.
Symbol

Please note, there is a significant difference between XTANT MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTANT MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTANT MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

XTANT MEDICAL 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to XTANT MEDICAL's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of XTANT MEDICAL.
0.00
04/25/2025
No Change 0.00  0.0 
In 2 months and 31 days
07/24/2025
0.00
If you would invest  0.00  in XTANT MEDICAL on April 25, 2025 and sell it all today you would earn a total of 0.00 from holding XTANT MEDICAL HLDGS or generate 0.0% return on investment in XTANT MEDICAL over 90 days. XTANT MEDICAL is related to or competes with Zoom Video, QLEANAIR, Pentair Plc, UNIVERSAL MUSIC, UNITED RENTALS, Warner Music, and Lendlease. Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for ... More

XTANT MEDICAL Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure XTANT MEDICAL's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess XTANT MEDICAL HLDGS upside and downside potential and time the market with a certain degree of confidence.

XTANT MEDICAL Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for XTANT MEDICAL's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as XTANT MEDICAL's standard deviation. In reality, there are many statistical measures that can use XTANT MEDICAL historical prices to predict the future XTANT MEDICAL's volatility.
Hype
Prediction
LowEstimatedHigh
0.030.514.99
Details
Intrinsic
Valuation
LowRealHigh
0.020.414.89
Details
Naive
Forecast
LowNextHigh
0.010.424.90
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.470.540.61
Details

XTANT MEDICAL HLDGS Backtested Returns

XTANT MEDICAL appears to be out of control, given 3 months investment horizon. XTANT MEDICAL HLDGS retains Efficiency (Sharpe Ratio) of 0.0996, which attests that the company had a 0.0996 % return per unit of volatility over the last 3 months. We have found twenty-eight technical indicators for XTANT MEDICAL, which you can use to evaluate the volatility of the company. Please utilize XTANT MEDICAL's Mean Deviation of 3.94, market risk adjusted performance of (3.26), and Standard Deviation of 5.15 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, XTANT MEDICAL holds a performance score of 7. The firm owns a Beta (Systematic Risk) of -0.22, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning XTANT MEDICAL are expected to decrease at a much lower rate. During the bear market, XTANT MEDICAL is likely to outperform the market. Please check XTANT MEDICAL's downside deviation, total risk alpha, value at risk, as well as the relationship between the information ratio and treynor ratio , to make a quick decision on whether XTANT MEDICAL's current price history will revert.

Auto-correlation

    
  0.30  

Below average predictability

XTANT MEDICAL HLDGS has below average predictability. Overlapping area represents the amount of predictability between XTANT MEDICAL time series from 25th of April 2025 to 9th of June 2025 and 9th of June 2025 to 24th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of XTANT MEDICAL HLDGS price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current XTANT MEDICAL price fluctuation can be explain by its past prices.
Correlation Coefficient0.3
Spearman Rank Test0.05
Residual Average0.0
Price Variance0.0

XTANT MEDICAL HLDGS lagged returns against current returns

Autocorrelation, which is XTANT MEDICAL stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting XTANT MEDICAL's stock expected returns. We can calculate the autocorrelation of XTANT MEDICAL returns to help us make a trade decision. For example, suppose you find that XTANT MEDICAL has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

XTANT MEDICAL regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If XTANT MEDICAL stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if XTANT MEDICAL stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in XTANT MEDICAL stock over time.
   Current vs Lagged Prices   
       Timeline  

XTANT MEDICAL Lagged Returns

When evaluating XTANT MEDICAL's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of XTANT MEDICAL stock have on its future price. XTANT MEDICAL autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, XTANT MEDICAL autocorrelation shows the relationship between XTANT MEDICAL stock current value and its past values and can show if there is a momentum factor associated with investing in XTANT MEDICAL HLDGS.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in XTANT Stock

XTANT MEDICAL financial ratios help investors to determine whether XTANT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTANT with respect to the benefits of owning XTANT MEDICAL security.